An overview of the relative risks of different sexual behaviours on HIV transmission

Current Opinion in HIV and AIDS

Volumn 5, Issue 4, 2010, Pages 291-297

  Dosekun, Olamide ^a   Fox, Julie ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

HIV transmission; Sex act

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; MICROBICIDE; PLACEBO;

ANUS INTERCOURSE; CD4 LYMPHOCYTE COUNT; CIRCUMCISION; CLINICAL TRIAL; CONDOM; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; EPIDEMIC; GENITAL ULCER; HEALTH EDUCATION; HETEROSEXUALITY; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; INFECTION SENSITIVITY; LIFE EXPECTANCY; MALE HOMOSEXUAL; ORAL SEXUAL CONTACT; PRIORITY JOURNAL; REVIEW; RISK FACTOR; RISK REDUCTION; SELF REPORT; SEROLOGY; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; UNSAFE SEX; VIRUS LOAD; VIRUS TRANSMISSION;

DISEASE TRANSMISSION, INFECTIOUS; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; RISK; SEXUAL BEHAVIOR;

EID: 77953614032     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0b013e32833a88a3     Document Type: Review

References (116)

1. UNAIDS. 2008 Report on the global HIV/AIDS epidemic.
2. World Health Organisation 2008. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress report 08.
3. Kilmarx PH. Global epidemiology of HIV. Curr Opin HIV AIDS 2009; 4:240-246.
4. Gilks CF, Crowley S, Ekpini R, et al. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet 2006; 368:505-510.
5. Fox J, Fidler S. Sexual transmission of HIV-1. Antiviral Res 2010; 85:276-285.
6. Baggaley RF, White RG, Boily MC. Systematic review of orogenital HIV-1 transmission probabilities. Int J Epidemiol 2008; 37:1255-1265.
7. Jin F, Jansson J, Law M, et al. Per-contact probability of HIV transmission in homosexual men in Sydney in the era of HAART. AIDS 2010; 24:907-913.
8. Priddy F, Hoang T, Wakasiaka S. Anal sex, sexually transmitted infections, and HIV incidence in female sex workers in urban Kenya. 17th Conference on Retroviruses and Opportunistic infections, Abstract 1024; 2010.
9. Sullivan PS, Salazar L, Buchbinder S, et al. Estimating the proportion of HIV transmissions from main sex partners among men who have sex with men in five US cities. AIDS 2009; 23:1153-1162.
10. Lattimore S, Thornton A, Delpech V, Elford J. Trends in sexual behaviour among London gay men between 98 and 08. In Proceedings of the International Society for Sexually Transmitted Diseases Research (ISSTDR) Conference; June 2009; London.
11. Jansen I, Geskus R, Davidovich U, et al. Increasing trend among young men who have sex with men in Amsterdam: a 25-year prospective cohort study. Seventeenth Conference on Retroviruses and Opportunistic Infections, Abstract 35; 2010.
12. Mah TL, Halperin DT. The evidence for the role of concurrent partnerships in Africa's HIV epidemics: a response to Lurie and Rosenthal. AIDS Behav 2010; 14:25-28.
13. Morris M. Barking up the wrong evidence tree. Comment on Lurie & Rosenthal, 'Concurrent partnerships as a driver of the HIV epidemic in sub-Saharan Africa? The evidence is limited'. AIDS Behav 2010; 14:31-33.
14. Mah TL, Halperin DT. Concurrent sexual partnerships and the HIV epidemics in Africa: evidence to move forward. AIDS Behav 2010; 14:11-16.
15. Morris M, Kretzschmar M. Concurrent partnerships and the spread of HIV. AIDS 1997; 11:641-648.
16. Lagarde E, Auvert B, Caraël M, et al. Concurrent sexual partnerships and HIV epidemic in five urban communities of sub-Saharan Africa. AIDS 2001; 15:877-884.
17. Lurie MN, Rosenthal S. Concurrent partnerships as a driver of the HIV epidemic in sub-Saharan Africa? The evidence is limited. AIDS Behav 2010; 14:17-24.
18. Lurie MN, Rosenthal S, Williams B. Concurrency driving the African HIV epidemics: where is the evidence? Lancet 2009; 374:1420.
19. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000; 342:921-929.
20. Wawer MJ, Gray RH, Sewankambo NK, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 2005; 1:1403-1409.
21. Wawer MJ, Sewankambo NK, Serwadda D, et al. Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group. Lancet 1999; 353:525-535.
22. Nagot N, Ouedraogo A, Foulongue V, et al. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. N Engl J Med 2007; 356:790-799.
23. MacKellar DA, Valleroy LA, Anderson JE, et al. Recent HIV testing among young men who have sex with men: correlates, contexts, and HIV seroconversion. Sex Trans Dis 2006; 33:183-192.
24. Keele BF, Giorgi EE, Salazar-Gonzalez JF, et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci 2008; 105:7552-7557.
25. Wilson D, Law M, Grulich A, et al. Relation between HIV viral load and infectiousness: a model-based analysis. Lancet 2008; 372:314-320.
26. Donnell D, Kiarie J, Thomas K, et al. ART and risk of heterosexual HIV-1 transmission in HIV-1 serodiscordant African couples: a multinational prospective study. Seventeenth Conference on Retroviruses and Opportunistic Infections, abstract 136; 2010.
27. HIV prevention trials network. HPTN 052: a randomized placebo-controlled trial to evaluate the effectiveness of antiretroviral therapy to prevent the sexual transmission of HIV-1 in serodiscordant couples. Available at http:// www.hptn.org/research-studies/hptn052.asp.
28. Gray RH, Wawer MJ, Brookmeyer R, et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 2001; 357:1149-1153.
29. Reynolds SJ, Risbud AR, Shepherd ME, et al. High rates of syphilis among STI patients are contributing to the spread of HIV-1 in India. Sex Transm Infect 2006; 82:121-126.
30. Gray RH, Li X, Kigozi G, et al. Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study. Lancet 2005; 366:1182-1188.
31. Bailey R, Moses S, Parker B, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 2007; 369:643-656.
32. Morrison CS, Richardson BA, Mmiro F, et al. Hormonal Contraception and the Risk of HIV Acquisition (HC-HIV) Study Group. Hormonal contraception and the risk of HIV acquisition. AIDS 2007; 21:85-95.
33. Berman M, CohenM. STD treatment how can it improve HIV prevention in the South? Sex Transm Dis 2006; 33:S50-S57.
34. Macdonald N, Elam G, Hickson F, et al. Factors associated with HIV seroconversion in gay men in England at the start of the 21st century. Sex Transm Infect 2008; 84:8-13.
35. Kapiga S, Sam N, Bang H, et al. The role of herpes simplex virus type 2 and other genital infections in the acquisition of HIV-1 among high-risk women in northern Tanzania. J Infect Dis 2007; 5:1260-1269.
36. McClelland R, Sangare L, Hassan W, et al. Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis 2007; 5:698-702.
37. Van Der Pol B, Kwok C, Pierre-Louis B, et al. Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. J Infect Dis 2008; 7:548-554.
38. Freeman E, Weiss H, Glynn J, et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 2006; 20:73-83.
39. Atashili J, Poole C, Ndumbe PM, et al. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS 2008; 22:1493-1501.
40. Auvert B, Taljaard D, Lagarde E, et al. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med 2005; 2:e298.
41. Gray RH, Kigozi G, Serwadda D, Makumbi F, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 2007; 369:657-666.
42. Gray RH, Kigozi G, Serwadda D, et al. The effects of male circumcision on female partners' genital tract symptoms and vaginal infections in a randomized trial in Rakai, Uganda. Am J Obstet Gynecol 2008; 200: 42.e1-42.e7.
43. Gust DA, Wiegand RE, Kretsinger K, et al. Circumcision status and HIV infection among MSM: reanalysis of a phase III HIV vaccine clinical trial. AIDS 2010 [Epub ahead of print]
44. Crepaz N, Marks G, Liau A, et al. HIV/AIDS Prevention Research Synthesis (PRS) Team. Prevalence of unprotected anal intercourse among HIVdiagnosed MSM in the United States: a meta-analysis. AIDS 2009; 23:1617-1629.
45. Schwarcz S, Scheer S, McFarland W, et al. Prevalence of HIV infection and predictors of high-transmission sexual risk behaviors among men who have sex with men. Am J Public Health 2007; 97:1067-1075.
46. Hart GJ, Elford J. Sexual risk behaviour of men who have sex with men: emerging patterns and new challenges. Curr Opin Infect Dis 2010; 23:39-44.
47. Health Protection Agency Centre for Infections. Sexually transmitted infections in men who have sex with men in the United Kingdom: 2008 report. London, United Kingdom, Health Protection Agency, 2008. Available from http://www.hpa.org.uk/hivmsm2008.
48. Brewer DD, Golden MR, Handsfield HH. Unsafe sexual behavior and correlates of risk in a probability sample of men who have sex with men in the era of highly active antiretroviral therapy. Sex Transm Dis 2006; 33:250-255.
49. Ostrow DG, Plankey MW, Cox C, et al. Specific sex drug combinations contribute to the majority of recent HIV seroconversions among MSM in the MACS. J Acquir Immune Defic Syndr 2009; 51:349-355.
50. Shoptaw S, Reback CJ. Review Methamphetamine use and infectious disease-related behaviors in men who have sex with men: implications for interventions. Addiction 2007; 102 (Suppl 1):130-135.
51. Marquez C, Mitchell SJ, Hare CB, et al. Methamphetamine use, sexual activity, patient-provider communication, and medication adherence among HIV-infected patients in care, San Francisco 04-06. AIDS Care 2009; 21:575-582.
52. Drumright LN, Gorbach PM, Little SJ, et al. Associations between substance use, erectile dysfunction medication and recent HIV infection among men who have sex with men. AIDS Behav 2009; 13:328-336.
53. Kalichman SC, Eaton L, White D, et al. Beliefs about treatments for HIV/AIDS and sexual risk behaviors among men who have sex with men, 97-06. J Behav Med 2007; 30:497-503. (Pubitemid 350171279)
54. Sullivan PS, Drake AJ, Sanchez TH. Prevalence of treatment optimismrelated risk behavior and associated factors among men who have sex with men in 11 states, 00-01. AIDS Behav 2007; 11:123-129.
55. Bakeman R, Peterson JL. Community Intervention Trial for Youth Study Team. Do beliefs about HIV treatments affect peer norms and risky sexual behaviour among African-American men who have sex with men? Int J STD AIDS 2007; 18:105-108.
56. Begley K, Chan DJ, Jeganathan S, et al. Factors associated with unprotected anal intercourse between HIV-positive men and regular male partners in a Sydney cohort. Int J STD AIDS 2009; 20:704-707.
57. Golden MR, Wood RW, Buskin SE, et al. Ongoing risk behavior among persons with HIV in medical care. AIDS Behav 2007; 11:726-735.
58. van Kesteren NM, Hospers HJ, Kok G. Sexual risk behavior among HIVpositive men who have sex with men: a literature review. Patient Educ Couns 2007; 65:5-20.
59. Heiligenberg M, Rijnders B, van der Loeff M. High prevalence of asymptomatic sexually transmitted infections in HIV+ MSM, visiting HIV outpatient clinics in The Netherlands. 17th Conference on Retroviruses and Opportunistic Infections, Abstract 11; 2010.
60. Fox J, White PJ, Macdonald N, et al. Reductions in HIV transmission risk behaviour following diagnosis of primary HIV infection: a cohort of high-risk men who have sex with men. HIV Med 2009; 10:432-438.
61. Fox J, Nastouli E, Thomson E, et al. Increasing incidence of acute hepatitis C in individuals diagnosed with primary HIV in the United Kingdom. AIDS 2008; 22:666-668.
62. McClelland RS, Graham SM, Richardson BA, et al. Treatment with antiretroviral therapy is not associated with increased sexual risk behavior in Kenyan female sex workers. AIDS 2010; 24:891-897.
63. Allen S, Meinzen-Derr J, Kautzman M, et al. Sexual behavior of HIV-discordant couples after HIV counseling and testing. AIDS 2003; 17:733-740.
64. Sherr L, Lopman B, Kakowa M, et al. Voluntary counseling and testing: uptake, impact on sexual behavior, and HIV incidence in a rural Zimbabwean cohort. AIDS 2007; 21:851-860.
65. Ryder RW, Kamenga C, Jingu M, et al. Pregnancy and HIV-1 incidence in 178 married couples with discordant HIV-1 serostatus: additional experience at an HIV-1 counselling centre in the Democratic Republic of the Congo. Trop Med Int Health 2000; 5:482-487.
66. Malamba SS, Mermin JH, Bunnell R, et al. Couples at risk: HIV-1 concordance and discordance among sexual partners receiving voluntary counseling and testing in Uganda. J Acquir Immune Defic Syndr 2005; 39:576-580.
67. Ostrow DG, Silverberg MJ, Cook RL, et al. Prospective study of attitudinal and relationship predictors of sexual risk in the multicenter AIDS cohort study. AIDS Behav 2008; 12:127-138.
68. Stollte IG, de Wit JBF, Kolader M. Association between 'safer sex fatigue' and rectal gonorrhea is mediated by unsafe sex with casual partners among HIV-positive homosexual men. Sex Transm Dis 2006; 33:201-208.
69. Cassels S, Menza TW, Goodreau SM, Golden MR. HIV serosorting as a harm reduction strategy: evidence from Seattle, Washington. AIDS 2009; 23:2497-2506.
70. Jin F, Crawford J, Prestage GP, et al. Unprotected anal intercourse, risk reduction behaviours, and subsequent HIV infection in a cohort of homosexual men. AIDS 2009; 23:243-252.
71. Elford J, Bolding G, Sherr L, Hart G. No evidence of an increase in serosorting with casual partners among HIV-negative gay men in London, 1998-2005. AIDS 2007; 21:243-245.
72. Mao L, Crawford JM, Hospers HJ, et al. 'Serosorting' in casual anal sex of HIV-negative gay men is noteworthy and is increasing in Sydney, Australia. AIDS 2006; 20:1204-1206.
73. Xia Q, Molitor F, Osmond DH, et al. Knowledge of sexual partner's HIV serostatus and serosorting practices in a California population-based sample of men who have sex with men. AIDS 2006; 20:2081-2089.
74. Golden MR, Stekler J, Hughes JP, Wood RW. HIV serosorting in men who have sex with men: is it safe? J Acquir Immune Defic Syndr 2008; 49:212-218.
75. Velter A, Bouyssou-Michel A, Arnaud A, Semaille C. Do men who have sex with men use serosorting with casual partners in France? Results of a nationwide survey (ANRS-EN17-Presse Gay 04). Euro Surveill 2009; 14:416.
76. Snowden JM, Raymond HF, McFarland W. Prevalence of seroadaptive behaviours of men who have sex with men, San Francisco, 04. Sex Transm Infect 2009; 85:469-476.
77. Eaton LA, Kalichman SC, O'Connell DA, et al. A strategy for selecting sexual partners believed to pose little/no risks for HIV: serosorting and its implications for HIV transmission. AIDS Care 2009; 21:1279-1288.
78. Zablotska IB, Imrie J, Prestage G. Gay men's current practice of HIV seroconcordant unprotected anal intercourse: serosorting or seroguessing? AIDS Care 2009; 21:501-510.
79. Weiss HA, Wasserheit JN, Barnabas RV, et al. Persisting with prevention: the importance of adherence for HIV prevention. Emerg Themes Epidemiol 2008; 5:8.
80. Hanenberg RS, Rojanapithayakorn W, Kunasol P, Sokal DC. Impact of Thailand's HIV control programme as indicated by the decline of sexually transmitted diseases. Lancet 1994; 344:243-245.
81. Underhill K, Operario D, Montgomery P. Systematic review of abstinenceplus HIV prevention programs in high-income countries. PLoS Med 2007; 4:e275.
82. Ross DA, Changalucha J, Obasi AI, et al. Biological and behavioural impact of an adolescent sexual health intervention in Tanzania: a communityrandomized trial. AIDS 2007; 21:43-55.
83. Watson-Jones D, Weiss HA, Rusizoka M, et al. Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med 2008; 358:1560-1571.
84. Celum C, Wald A, Hughes J, et al. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet 2008; 371:2109-2119.
85. Bowen AM, Horvath K, Williams ML. Randomized control trial of an Internet delivered HIV knowledge intervention with MSM. Health Educ Res 2006; 22:1-127.
86. Kok G, Harterink P, Vriens P, et al. The gay cruise: developing a theory- and evidence-based internet HIV-prevention intervention. Sexual Res Soc Policy 2006; 3:52-67.
87. Bowen AM, Williams ML, Daniel CM, Clayton S. Internet based HIV prevention research targeting rural MSM: feasibility, acceptability, and preliminary efficacy. J Behav Med 2008; 31:463-477.
88. Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS 2006; 20:1447-1450.
89. Vernazza P, Hirschel B, Bernasconi E. Les personnes sé ropositives ne souffrant d'aucune autre MST et suivant un traitment antiré troviral efficace ne transmettent pas le VIH par voie sexuelle. Bulletin des mé decins suisses 2008; 89:18-21.
90. Jewkes R, Nduna M, Levin J, et al. Impact of stepping stones on incidence of HIV and HSV-2 and sexual behaviour in rural South Africa: cluster randomised controlled trial. Br Med J 2008; 337:a506.
91. Coates TJ, Richter L, Caceres C. Behavioural strategies to reduce HIV transmission: how to make them work better. Lancet 2008; 372:669-684.
92. Burton J, Darbes LA, Operario D. Couples-focused behavioral interventions for prevention of HIV: systematic review of the state of evidence. AIDS Behav 2010; 14:1-10.
93. Johnson WD, Diaz RM, Flanders WD, et al. Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men. Cochrane Database Syst Rev 2008; CD001230.
94. Dilley JW, Woods WJ, et al. Brief cognitive counseling with HIV testing to reduce sexual risk among men who have sex with men: results from a randomized controlled trial using paraprofessional counselors. J Acquir Immune Defic Synd 2007; 44:569-577.
95. Lima VD, Johnston K, Hogg RS, et al. Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic. J Infect Dis 2008; 8:59-67.
96. Potts M, Halperin DT, Kirby D, et al. Public health. Reassessing HIV prevention. Science 2008; 3:749-750.
97. Cornman DH, Kiene SM, Christie S, et al. Clinic-based intervention reduces unprotected sexual behavior among HIV-infected patients in KwaZulu-Natal, South Africa: results of a pilot study. J Acquir Immune Defic Syndr 2008; 48:553-560.
98. Gilbert P, Ciccarone D, Gansky SA, et al. Interactive 'video doctor' counseling reduces drug and sexual risk behaviors among HIV-positive patients in diverse outpatient settings. PLoS One 2008; 3:e88.
99. Barouch DH. Challenges in the development of an HIV-1 vaccine. Nature 2008; 455:613-616.
100. Skoler-Karpoff S, Ramjee G, Ahmed K, et al. Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, doubleblind, placebo-controlled trial. Lancet 2008; 372:77-87.
101. Van Damme L, Govinden R, Mirembe F, et al. Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. N Engl J Med 2008; 359:463-472.
102. Grant RM, Hamer D, Hope T, Johnston R, et al. Whither or wither microbicides? Science 2008; 321:532-534.
103. Chisembele M, Crook A, GafosM, et al. PRO2000 vaginal gel is ineffective in preventing HIV infection: results of the MDP301 phase III microbicide trial. Seventeenth Conference on Retroviruses and Opportunistic Infections, Oral 24; 2010.
104. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, et al., MOPH-TAVEG Investigators. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 2009; 361:2209-2220.
105. Quinn TC. Circumcision and HIV transmission. Curr Opin Infect Dis 2007; 20:33-38.
106. Weiss HA. Male circumcision as a preventive measure against HIV and other sexually transmitted diseases. Curr Opin Infect Dis 2007; 20:66-72.
107. Mills E, Cooper C, Anema A, Guyatt G. Male circumcision for the prevention of heterosexually acquired HIV infection: a meta-analysis of randomized trials involving 11,050 men. HIV Med 2008; 9:332-335.
108. Mocroft A, Vella S, Benfield TL, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet 1998; 352:1725-1730.
109. Bezemer D, de Wolf F, BoerlijstMC, et al. A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy. AIDS 2008; 22:1071-1077.
110. Eaton LA, Kalichman S. Risk compensation in HIV prevention: implications for vaccines, microbicides, and other biomedical HIV prevention technologies. Curr HIV/AIDS Rep 2007; 4:165-172.
111. Bechange S, Bunnell R, Awor A, et al. Two-year follow-up of sexual behavior among HIV-uninfected household members of adults taking antiretroviral therapy in Uganda: no evidence of disinhibition. AIDS Behav 2008 [Epub ahead of print].
112. Eisele TP, Mathews C, Chopra M, et al. High levels of risk behavior among people living with HIV Initiating and waiting to start antiretroviral therapy in Cape Town South Africa. AIDS Behav 2008; 12:570-577.
113. Bateganya M, Colfax G, Shafer LA, et al. Antiretroviral therapy and sexual behavior: a comparative study between antiretroviral- naive and -experienced patients at an urban HIV/AIDS care and research center in Kampala, Uganda. AIDS Patient Care STDS 2005; 19:760-768.
114. Crepaz N, Hart TA, Marks G. Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review. J Am Med Assoc 2004; 292:224-236.
115. García-Lerma JG, Otten RA, Qari SH, et al. Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir. PLoS Med 2008; 5:e28.
116. Denton PW, Estes JD, Sun Z, et al. Antiretroviral preexposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice. PLoS Med 2008; 5:e16.